Evidence map›Paper›PMID 41676062›Full record

ReviewFrontiers in microbiology2026

Advances in microbial sulfoquinovose catabolism.

Yiwei Chen, Dazhi Liu, Ruoxing Chu, Zongyuan Li, Yueya Zhang, Kailiang Ma, Li Jiang, Qiaoyu Yang, Fengxia Lu, Yan Zhang and 1 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yiwei Chen *College of Food Science and Technology, Nanjing Agricultural University, Nanjing, China.
Dazhi LiuNew Cornerstone Science Laboratory, School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China.
Ruoxing ChuNew Cornerstone Science Laboratory, School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China.
Zongyuan LiNew Cornerstone Science Laboratory, School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China.
Yueya ZhangNew Cornerstone Science Laboratory, School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China.
Kailiang MaNew Cornerstone Science Laboratory, School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China.
Li JiangNew Cornerstone Science Laboratory, School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China.
Qiaoyu YangNew Cornerstone Science Laboratory, School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China.
Fengxia LuCollege of Food Science and Technology, Nanjing Agricultural University, Nanjing, China.
Yan ZhangNew Cornerstone Science Laboratory, School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China.
Yang TongNew Cornerstone Science Laboratory, School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sulfoquinovose (SQ) serves as the polar head group of sulfolipids in photosynthetic organisms. Given the substantial biomass of these organisms, the estimated global annual production of SQ is around 10 billion tons, making it one of the most abundant sulfur-containing organic compounds in nature. The microbial degradation of SQ constitutes a critical component of the global sulfur cycle and is increasingly recognized for its relevance to human health, particularly through its metabolism by the gut bacteria. Microorganisms employ two principal classes of catabolic pathways to degrade SQ: (

Indexed as

C-C bond cleavageC-S bond cleavagesulfoglycolysissulfonatessulfoquinovosesulfur cycle

Identifiers

PMID41676062
PMCPMC12890257

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.